BioCentury
ARTICLE | Clinical News

Voncento regulatory update

July 20, 2015 7:00 AM UTC

EMA’s CHMP recommended extending the indication of Voncento from CSL to include prophylaxis and treatment of hemorrhage or surgical bleeding in patients with von Willebrand disease (vWD) when desmopre...